Red flags: when nausea needs medical attention Most GLP-1 nausea is mild to moderate and self-limiting
Tirzepatide should be administered on the same day each week, and the day of weekly administration can be changed if necessary, provided at least three days (72 hours) have elapsed between doses
Leaving a vial at room temperature for an extended period, like overnight, will significantly accelerate its degradation
Comorbidities : Other metabolic conditions, such as the presence of type 2 diabetes, osteoarthritis, obstructive sleep apnea, and heart disease, also influence the effect of medication
Physical examination should assess hydration status, muscle strength, and signs of nutritional deficiency